Evidence map›Paper›PMID 32618250›Full record

ArticleThe American journal of tropical medicine and hygiene2020

Recent Travel History and

Travis R Porter, Timothy P Finn, Kafula Silumbe, Victor Chalwe, Busiku Hamainza, Emmanuel Kooma, Hawela Moonga, Adam Bennett, Joshua O Yukich, Richard W Steketee and 3 more

Open access · hybridAbstract read
In one paragraph

Article in The American journal of tropical medicine and hygiene, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.3field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 15 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 2 countries.

Travis R Porter1Department of Tropical Medicine, Center for Applied Malaria Research and Evaluation, Tulane University School of Public Health and Tropical Medicine, New Orleans, Louisiana.
Timothy P Finn1Department of Tropical Medicine, Center for Applied Malaria Research and Evaluation, Tulane University School of Public Health and Tropical Medicine, New Orleans, Louisiana.
Kafula Silumbe2PATH Malaria Control and Elimination Partnership in Africa (MACEPA), Lusaka, Zambia.
Victor Chalwe3National Malaria Elimination Centre, Zambia Ministry of Health, Lusaka, Zambia.
Busiku Hamainza3National Malaria Elimination Centre, Zambia Ministry of Health, Lusaka, Zambia.
Emmanuel Kooma3National Malaria Elimination Centre, Zambia Ministry of Health, Lusaka, Zambia.
Hawela Moonga3National Malaria Elimination Centre, Zambia Ministry of Health, Lusaka, Zambia.
Adam Bennett4Malaria Elimination Initiative, Global Health Group, University of California San Francisco, San Francisco, California.
Joshua O Yukich1Department of Tropical Medicine, Center for Applied Malaria Research and Evaluation, Tulane University School of Public Health and Tropical Medicine, New Orleans, Louisiana.
Richard W Steketee5PATH MACEPA, Seattle, Washington.
Joseph Keating1Department of Tropical Medicine, Center for Applied Malaria Research and Evaluation, Tulane University School of Public Health and Tropical Medicine, New Orleans, Louisiana.
John M Miller2PATH Malaria Control and Elimination Partnership in Africa (MACEPA), Lusaka, Zambia.
Thomas P Eisele1Department of Tropical Medicine, Center for Applied Malaria Research and Evaluation, Tulane University School of Public Health and Tropical Medicine, New Orleans, Louisiana.
Tulane University · USMinistry of Health · ZMNational HIV/AIDS/STI/TB Council · ZMProgram for Appropriate Technology in Health · USUniversity of California, San Francisco · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

As Zambia continues to reduce its malaria incidence and target elimination in Southern Province, there is a need to identify factors that can reintroduce parasites and sustain malaria transmission. To examine the relative contributions of types of human mobility on malaria prevalence, this analysis quantifies the proportion of the population having recently traveled during both peak and nonpeak transmission seasons over the course of 2 years and assesses the relationship between short-term travel and malaria infection status. Among all residents targeted by mass drug administration in the Lake Kariba region of Southern Province, 602,620 rapid diagnostic tests and recent travel histories were collected during four campaign rounds occurring between December 2014 and February 2016. Rates of short-term travel in the previous 2 weeks fluctuated seasonally from 0.3% to 1.2%. Travel was significantly associated with prevalent malaria infection both seasonally and overall (adjusted odds ratio [AOR]: 2.55; 95% CI: 2.28-2.85). The strength of association between travel and malaria infection varied by travelers' origin and destination, with those recently traveling to high-prevalence areas from low-prevalence areas experiencing the highest odds of malaria infection (AOR: 7.38). Long-lasting insecticidal net usage while traveling was associated with a relative reduction in infections (AOR: 0.74) compared with travelers not using a net. Although travel was directly associated with only a small fraction of infections, importation of malaria via human movement may play an increasingly important role in this elimination setting as transmission rates continue to decline.

Indexed as

Plasmodium falciparumTravelAdolescentAntimalarialsArtemisininsChildChild, PreschoolDrug Therapy, CombinationFamily CharacteristicsFemaleHumansMalaria, FalciparumMaleMass Drug AdministrationPiperazinesPrevalenceAntimalarialsArtemisininsartenimolpiperaquinePiperazinesQuinolines

Identifiers

PMID32618250
PMCPMC7416974
OpenAlexW3040383184

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.